BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 30658592)

  • 1. Pneumocystis jirovecii-related spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema in a liver transplant recipient: a case report.
    She WH; Chok KSH; Li IWS; Ma KW; Sin SL; Dai WC; Fung JYY; Lo CM
    BMC Infect Dis; 2019 Jan; 19(1):66. PubMed ID: 30658592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly formed cystic lesions for the development of pneumomediastinum in Pneumocystis jirovecii pneumonia.
    Cho JY; Kim DM; Kwon YE; Yoon SH; Lee SI
    BMC Infect Dis; 2009 Oct; 9():171. PubMed ID: 19835635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An outbreak of Pneumocytis jirovecii pneumonia among liver transplant recipients.
    Miguel Montanes R; Elkrief L; Hajage D; Houssel P; Fantin B; Francoz C; Dreyfuss D; Ricard JD; Durand F
    Transpl Infect Dis; 2018 Oct; 20(5):e12956. PubMed ID: 29896781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A heart transplant recipient lost due to Pneumocystis jiroveci pneumonia under trimethoprim-sulfamethoxazole prophylaxis: case report.
    Celik T; Gedik E; Kayabas U; Bayindir Y; Gulbas G; Firat AK; Togal T
    Exp Clin Transplant; 2010 Dec; 8(4):325-8. PubMed ID: 21143101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report.
    Kuroda T; Takeuchi H; Nozawa Y; Sato H; Nakatsue T; Wada Y; Moriyama H; Nakano M; Narita I
    BMC Res Notes; 2016 Apr; 9():240. PubMed ID: 27113212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of once-weekly dapsone dosing for Pneumocystis jirovecii pneumonia prophylaxis post transplantation.
    Evans RA; Clifford TM; Tang S; Au T; Fugit AM
    Transpl Infect Dis; 2015 Dec; 17(6):816-21. PubMed ID: 26369753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis.
    Andreasen PB; Rezahosseini O; Møller DL; Wareham NE; Thomsen MT; Houmami R; Knudsen AD; Knudsen J; Kurtzhals JAL; Rostved AA; Pedersen CR; Rasmussen A; Nielsen SD
    Immun Inflamm Dis; 2022 Jan; 10(1):93-100. PubMed ID: 34713963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole.
    Kato H; Samukawa S; Takahashi H; Nakajima H
    J Infect Chemother; 2019 Nov; 25(11):920-924. PubMed ID: 31300379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Rare Case of 4 Ps: Bilateral Pneumothoraces and Pneumomediastinum in Pneumocystis Pneumonia.
    Yee D; Fu D; Hui C; Dharmadhikari N; Carino G
    R I Med J (2013); 2020 Jun; 103(5):52-54. PubMed ID: 32481782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low incidence of Pneumocystis jirovecii pneumonia in an unprophylaxed liver transplant cohort.
    Sarwar S; Carey B; Hegarty JE; McCormick PA
    Transpl Infect Dis; 2013 Oct; 15(5):510-5. PubMed ID: 23930824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pneumocystis pneumonia in a renal transplant recipient].
    Özkoç S; İnceboz T; Sıfıl A; Tuncay S; Akisü Ç
    Turkiye Parazitol Derg; 2010; 34(4):186-9. PubMed ID: 21391190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of beta-D glucan in diagnosing Pneumocystis carinii pneumonia and monitoring its treatment in a living-donor liver-transplant recipient.
    Kawagishi N; Miyagi S; Satoh K; Akamatsu Y; Sekiguchi S; Satomi S
    J Hepatobiliary Pancreat Surg; 2007; 14(3):308-11. PubMed ID: 17520208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-onset Pneumocystis jirovecii pneumonia in solid organ transplant recipients.
    Perez-Ordoño L; Hoyo I; Sanclemente G; Ricart MJ; Cofan F; Perez-Villa F; de la Bellacasa JP; Moreno A; Cervera C
    Transpl Infect Dis; 2014 Apr; 16(2):324-8. PubMed ID: 24456244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.
    Ye WL; Tang N; Wen YB; Li H; Li MX; Du B; Li XM
    Int Urol Nephrol; 2016 Nov; 48(11):1863-1871. PubMed ID: 27351666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
    Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
    Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
    Wang EH; Partovi N; Levy RD; Shapiro RJ; Yoshida EM; Greanya ED
    Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii.
    Rostved AA; Sassi M; Kurtzhals JA; Sørensen SS; Rasmussen A; Ross C; Gogineni E; Huber C; Kutty G; Kovacs JA; Helweg-Larsen J
    Transplantation; 2013 Nov; 96(9):834-42. PubMed ID: 23903011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complication of Pneumocystis jiroveci pneumonia.
    Mina NM; Soubani AO
    Respiration; 2011; 82(3):288-9. PubMed ID: 21701155
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV patients: A report of two cases and literature review.
    Markantonatou AM; Ioakimidou A; Arvaniti K; Manou E; Papadopoulos V; Kiriklidou P; Samaras K; Kioumi A; Vyzantiadis TA
    Mycoses; 2017 Oct; 60(10):626-633. PubMed ID: 28660636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.
    Salzer HJF; Schäfer G; Hoenigl M; Günther G; Hoffmann C; Kalsdorf B; Alanio A; Lange C
    Respiration; 2018; 96(1):52-65. PubMed ID: 29635251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.